Tag : clinical testing

Clinical Intelligence/Clinical Efficiency

Ajax Therapeutics Raises $40 Million

Business Wire
Financing led by EcoR1 Capital with additional new investor, Boxer Capital Strategic collaboration with co-founder, Schrödinger, Inc., to develop pipeline of selectively targeted therapeutics Founding...
Clinical Intelligence/Clinical Efficiency

BostonGene’s Acceptance of Abstracts to 2021 ASCO Annual Meeting

Business Wire
BostonGene Corporation, a biomedical software company focused on defining optimal, precision medicine-based therapies for cancer patients, today announced that two abstracts have been accepted for...
Clinical Intelligence/Clinical Efficiency

Clinical Intelligence Leader Inteliquetâ„¢ Highlights RWD Analysis

PR Newswire
Real World Data Utilizing Patient Matching Technology Suggests the Same Treatment Regimen Delivered in Different Sequences Results in Different Outcomes Inteliquet, highlighted today Real World...
Clinical Intelligence/Clinical Efficiency

Clinical Intelligence Company Caribou Biosciences Adds New Member

Business Wire
Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that it has expanded its scientific advisory board (SAB) with the appointment of...
Clinical Intelligence/Clinical Efficiency

Healthcare Tech Report Recognizes Wolters Kluwer’s Karen Kobelski

Business Wire
Wolters Kluwer, Health, a leading global provider of trusted clinical technology and evidence-based solutions, today announced that Karen Kobelski, Vice President and General Manager for Clinical...
Clinical Intelligence/Clinical Efficiency

Medical Intelligence Platform Dr.Evidence Expands Sr. Leadership

Business Wire
Unveils New Identity Emblematic of Purpose: Accelerated Impactâ„¢ Dr.Evidenceâ„¢, the leading medical intelligence platform for life sciences companies, today announced a slate of key commercial...
Clinical Intelligence/Clinical Efficiency

Interline Therapeutics Launches With $92 Million

Business Wire
Investment from Foresite Capital and ARCH Venture Partners will support platform development and therapeutic programs focused on inflammatory disease and cancer Interline Therapeutics, a Foresite...